Insight Molecular Diagnostics (IMDX) Receivables - Net: 2020-2025
Historic Receivables - Net for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $258,000.
- Insight Molecular Diagnostics' Receivables - Net rose 23.44% to $258,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $258,000, marking a year-over-year increase of 23.44%. This contributed to the annual value of $1.6 million for FY2024, which is 233.26% up from last year.
- As of Q3 2025, Insight Molecular Diagnostics' Receivables - Net stood at $258,000, which was down 49.61% from $512,000 recorded in Q2 2025.
- In the past 5 years, Insight Molecular Diagnostics' Receivables - Net registered a high of $3.5 million during Q1 2025, and its lowest value of $85,000 during Q2 2024.
- In the last 3 years, Insight Molecular Diagnostics' Receivables - Net had a median value of $512,000 in 2025 and averaged $858,909.
- Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 5,307.69% in 2021, then slumped by 88.50% in 2024.
- Over the past 5 years, Insight Molecular Diagnostics' Receivables - Net (Quarterly) stood at $1.4 million in 2021, then declined by 2.57% to $1.4 million in 2022, then slumped by 65.43% to $484,000 in 2023, then surged by 233.26% to $1.6 million in 2024, then climbed by 23.44% to $258,000 in 2025.
- Its Receivables - Net was $258,000 in Q3 2025, compared to $512,000 in Q2 2025 and $3.5 million in Q1 2025.